Rubbish Talk app Cut the spin.
Read the facts.
Suspicious of a headline?
Check it.
Rubbish Check
CNBC Top News · 20 August 2026 source

“Walmart stock tumbles 9% after outlook disappoints Wall Street”

R6/ 10
Spin-heavy
Rubbish Rating — 1 = base fact, 10 = pure rubbish
12345678910
In short
Rubbish Talk rates CNBC's claim that Walmart's "outlook disappoints Wall Street" a 6/10 because Walmart actually raised its full-year revenue and EPS guidance that same day, and the stock drop was driven by a comparable-sales miss, not a worse outlook.
The Verdict
Spin-heavy. The headline's own word, "outlook," is the opposite of what happened: Walmart lifted its full-year net-sales growth guidance to 4-5% from 3.5-4.5% and raised adjusted EPS guidance to $2.80-$2.87 from $2.75-$2.85. The 9% drop was driven by U.S. comparable sales coming in at 2.6% against a roughly 3.5-3.8% Wall Street estimate, a distinct fact the headline conflates with "outlook." The article body gets this right further down; the headline doesn't.

What actually happened

Walmart's fiscal Q2 revenue rose 5.9% to $187.94 billion, beating the $186.77 billion analysts expected, and adjusted EPS of 81 cents topped estimates too. Shares still fell about 9% because U.S. comparable sales grew only 2.6%, well short of what Wall Street had modeled, partly due to a 0.8-point drag from new drug price caps. Walmart simultaneously raised both its full-year sales and EPS guidance.

Key facts

  • Revenue: $187.94B actual vs. $186.77B expected (FactSet/LSEG survey), up 5.9% year over year
  • Adjusted EPS: 81 cents actual vs. 74 cents expected
  • U.S. comparable sales: 2.6% actual vs. roughly 3.5-3.8% expected across analyst surveys cited by outlets, a 0.8-point headwind from health and wellness price caps
  • Raised FY guidance: net sales now seen up 4-5% (was 3.5-4.5%); adjusted EPS now seen at $2.80-$2.87 (was $2.75-$2.85)
  • Stock closed down about 9% on the day, its worst single-day move in years per other outlets

What to watch for

Watch Q3 comparable-sales prints for whether the drug-price-cap drag persists or fades as a base effect, and whether the roughly $2.9 billion in tariff refunds Walmart is passing through as price cuts shows up in margin or volume next quarter. Also watch whether coverage keeps calling this an "outlook miss" even as the raised full-year guidance stands unchanged in subsequent filings.

About this scoreThe R-Score is Rubbish Talk's editorial opinion on how far a headline's framing sits from what the underlying facts support. It is a judgement about presentation and emphasis, not an allegation that any outlet has acted dishonestly. Every figure we rely on is linked under Receipts so you can check it yourself.
Share this CheckXFacebookLinkedInEmail